Trial NCT02200380

View at ClinicalTrials.gov 
Org. Study IDs: CDX301-03

Last trial update was posted on 2017-04-07

MeSH Interventions

Plerixafor

MeSH Conditions

Hodgkin Disease Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Acute Lymphoma, Non-Hodgkin Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma Preleukemia

Other Conditions

Acute Lymphoblastic Leukemia (ALL) Acute Myelogenous Leukemia (AML) Chronic Lymphocytic Leukemia (CLL) Chronic Myelogenous Leukemia (CML) For Donors For Recipients Hodgkins Disease (HD) Myelodysplastic Syndrome (MDS) Non-Hodgkins Lymphoma (NHL) Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID